Pyrrolidine derivatives as NK3 receptor antagonists

Details for Australian Patent Application No. 2010288666 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Jablonski, Philippe; Knust, Henner; Nettekoven, Matthias; Patiny-Adam, Angelique; Ratni, Hasane; Riemer, Claus

Agent Spruson & Ferguson

Pub. Number AU-A-2010288666

PCT Pub. Number WO2011/023626

Priority 09168630.3 25.08.09 EP

Filing date 20 August 2010

Wipo publication date 3 March 2011

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4545 (2006.01)

A61K 31/497 (2006.01)

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

2 February 2012 PCT application entered the National Phase

  PCT publication WO2011/023626 Priority application(s): WO2011/023626

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010288716-Nano silver-zinc oxide composition

2010288663-Velocity factor